OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies
Ali Oubella, Az‐Eddine El Mansouri, Mourad Fawzi, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105184-105184
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation – A systematic computational approach to discover novel cancer therapeutics
Bharath Kumar Chagaleti, Shantha Kumar B., Anjana G.V., et al.
Computational Biology and Chemistry (2024) Vol. 112, pp. 108134-108134
Closed Access | Times Cited: 17

4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design
Piotr Roszczenko, Serhii Holota, Olga Szewczyk‐Roszczenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13135-13135
Open Access | Times Cited: 45

Molecular hybrids based on 1,2,3-triazole and 1,3,4-thiadiazole cores: Synthesis, characterization, anticancer activity and in silico study
Ali Oubella, Abdoullah Bimoussa, Md Tabish Rehman, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138339-138339
Closed Access | Times Cited: 11

Targeted synthesis via the structure-activity relationship: Biological evaluation of new 1,2,3-triazoles monoterpene as antitumor agents
Ezaddine Irrou, Younesse Ait Elmachkouri, Soukaina El Haddad, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138025-138025
Closed Access | Times Cited: 10

Discovery of novel thiazolidinone-1,2,3-triazole hybrids with (D)-Limonene skeleton as anticancer agents: Design, synthesis and biological evaluation
Yousef E. Mukhrish, Nasser Amri, Jehan Y. Al‐Humaidi, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138127-138127
Closed Access | Times Cited: 9

Thymol-1,2,3-triazole derivatives: Network Pharmacology, Molecular Simulations and Synthesis Targeting Breast Cancer
Yassine Laamari, Abdoullah Bimoussa, Bharath Kumar Chagaleti, et al.
Journal of Molecular Structure (2024), pp. 140060-140060
Closed Access | Times Cited: 8

Tandem Synthesis and Computational Insights into Triazole and Pyrazole-Based Pyridine Derivatives Targeting EGFR-TK in Cancer Therapy
Samir Bondock, Nada Alabbad, Rehab H. Abd El‐Aleam, et al.
Polycyclic aromatic compounds (2025), pp. 1-24
Closed Access | Times Cited: 1

The Bioactivity of Thiazolidin-4-Ones: A Short Review of the Most Recent Studies
Dominika Mech, Antonina Kurowska, Nazar Trotsko
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11533-11533
Open Access | Times Cited: 46

New 1,2,3-Triazoles from (R)-Carvone: Synthesis, DFT Mechanistic Study and In Vitro Cytotoxic Evaluation
Ali Oubella, Abdoullah Bimoussa, Abdellah N’ait Oussidi, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 769-769
Open Access | Times Cited: 32

Green synthesis of 1,4-disubstituted 1,2,3-triazoles: a sustainable approach
Sachin Kumar, Bajrang Lal, Ram Kumar Tittal
Green Chemistry (2023) Vol. 26, Iss. 4, pp. 1725-1769
Closed Access | Times Cited: 22

Novel pyridine-thiazolidinone-triazole hybrid glycosides targeting EGFR and CDK-2: Design, synthesis, anticancer evaluation, and molecular docking simulation
Asmaa F. Kassem, Mohamed A. Omar, Eman S. Nossier, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136358-136358
Closed Access | Times Cited: 18

Design, Synthesis, Cytotoxic Effect Evaluation and Molecular Docking of (R)‐Camphor‐Based Thiazolidinone‐Isoxazole and Thiazolidinone‐1,2,3‐triazole Hybrids“
Abdellah N’Ait Ousidi, Abdoullah Bimoussa, Mohammed Loubidi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 1
Closed Access | Times Cited: 17

Synthesis, experimental, theoretical, and molecular dynamic studies of 1-(2,5-dimethoxy-4-methylphenyl)ethan-1-thiosemicarbazone as green inhibitor for carbon steel corrosion
Esseddik Elqars, Yassine Laamari, Karima Sadik, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135228-135228
Closed Access | Times Cited: 17

Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation, in silico studies, molecular docking, molecular dynamics simulations, and ADMET profiling
Abdoullah Bimoussa, Mourad Fawzi, Ali Oubella, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11987-11999
Closed Access | Times Cited: 14

Thiazolidinone‐Heterocycle Frameworks: A Concise Review of Their Pharmacological Significance
Pule Seboletswe, Nosipho Cele, Parvesh Singh
ChemMedChem (2023) Vol. 18, Iss. 7
Closed Access | Times Cited: 13

Synthesis and characterization of bis-isoxazoline-thiosemicarbazone as a corrosion inhibitor for carbon steel: Experimental study, and molecular simulation
Esseddik Elqars, Abdoullah Bimoussa, Ali Barhoumi, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138476-138476
Closed Access | Times Cited: 5

Synthesis, Anticancer Activity and Molecular Docking Studies of Hybrid Molecules Containing Indole‐Thiazolidinedione‐Triazole Moieties
Nagaraju Perike, Praveen Kumar Edigi, Nirmala Gurrapu, et al.
ChemistrySelect (2022) Vol. 7, Iss. 47
Closed Access | Times Cited: 21

Synthesis, antiproliferative activity, 3D‐QSAR, and molecular docking studies of novel L‐carvone‐derived pyrimidine‐urea compounds
Yupei Meng Meng, Yunxue Zhang Zhang, Wengui Duan, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 3, pp. 483-495
Closed Access | Times Cited: 4

Thiazolidinone-linked-1,2,3-triazoles with (R)-Carvone as new potential anticancer agents
Ali Oubella, Manal A. Alossaimi, Yassine Riadi, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 14, pp. 1449-1464
Closed Access | Times Cited: 4

Hybrid of the 1,2,3‐triazole nucleus and sesquiterpene skeleton as a potential antitumor agent: Hemisynthesis, molecular structure, Hirshfeld surface analysis, density functional theory, and in vitro cytotoxic and apoptotic effects
Abdoullah Bimoussa, Ali Oubella, Yassine Laamari, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 12, pp. 2334-2347
Closed Access | Times Cited: 25

Page 1 - Next Page

Scroll to top